Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all.
Project 1: National Immunization Strengthening Program
Specific: Train and equip healthcare workers in remote areas to deliver essential vaccines included in the national immunization program.
Measurable: Track the number of healthcare workers trained, monitor the proportion of the target population covered by each vaccine.
Achievable: Partner with international health organizations and NGOs, utilize mobile clinics and innovative delivery methods.
Result-Oriented: Increase the national immunization coverage rate for all program vaccines by 10% within one year.
Time-Bound: Develop training materials within 2 months, conduct training workshops within 4 months, and monitor coverage data for 1 year.
Impact Assessment:
3.b.1: Analyze national immunization registry data to assess the proportion of the target population covered by each vaccine.
Project 2: Local Vaccine Production and Manufacturing Initiatives
Specific: Partner with developing countries to establish local vaccine production facilities for priority diseases.
Measurable: Track the number of facilities established, monitor the volume of vaccines produced domestically.
Achievable: Partner with pharmaceutical companies and technology transfer organizations, secure funding through international aid agencies.
Result-Oriented: Increase domestic vaccine production capacity by 20% within two years.
Time-Bound: Secure funding and finalize facility locations within 6 months, complete construction and technology transfer within 18 months, and monitor production data for 2 years.
Impact Assessment:
3.b.2: Track the total net official development assistance (ODA) allocated to support vaccine research and production in developing countries.
Project 3: Essential Medicines Procurement and Distribution Systems
Specific: Establish a centralized procurement system for essential medicines and improve distribution networks to reach remote health facilities.
Measurable: Track the volume and cost of essential medicines procured, monitor delivery rates and stock availability at health facilities.
Achievable: Partner with national governments and pharmaceutical suppliers, utilize innovative supply chain management techniques.
Result-Oriented: Increase the availability of essential medicines in at least 80% of health facilities within one year.
Time-Bound: Develop procurement guidelines within 2 months, establish distribution networks within 4 months, and monitor stock availability data for 1 year.
Impact Assessment:
3.b.3: Track the proportion of health facilities reporting consistent availability and affordability of a core set of essential medicines.
Project 4: Public-Private Partnerships for Neglected Tropical Disease (NTD) Control
Specific: Partner with pharmaceutical companies to develop and distribute affordable treatments for neglected tropical diseases prevalent in developing countries.
Measurable: Track the number of new NTD treatments developed and registered, monitor the number of patients treated.
Achievable: Partner with NGOs specializing in NTDs, leverage public funding to incentivize private sector investment.
Result-Oriented: Increase the number of people treated for NTDs by 25% within three years.
Time-Bound: Secure partnerships and funding within 6 months, develop and register new treatments within 2 years, and monitor treatment data for 3 years.
Impact Assessment:
3.b.1: Track the inclusion of new NTD treatments in national program guidelines and subsequent increases in coverage rates.
3.b.2: Monitor official development assistance specifically allocated towards NTD research and treatment programs.
Project 5: Telemedicine for Remote Healthcare Access
Specific: Implement telemedicine platforms to connect patients in remote areas with healthcare specialists for diagnosis and treatment guidance.
Measurable: Track the number of telemedicine consultations conducted, monitor the types of conditions diagnosed and treatment plans provided.
Achievable: Partner with telemedicine service providers, train healthcare workers in remote areas to utilize the technology.
Result-Oriented: Increase access to specialist consultations for patients in remote areas by 30% within one year.
Time-Bound: Develop telemedicine infrastructure and training materials within 3 months, pilot the program in a selected region within 6 months, and expand based on success within 1 year.
Impact Assessment:
3.b.3: Track the availability of essential medicines in remote health facilities based on referrals and treatment plans facilitated through telemedicine consultations.
Project 6: Mobile Health Clinics for Underserved Communities
Specific: Establish mobile healthcare clinics equipped with essential medicines and staffed by qualified medical personnel to provide services in underserved communities.
Measurable: Track the number of communities served, monitor the number of patients treated and types of services provided.
Achievable: Partner with national health ministries and NGOs specializing in mobile healthcare services, secure funding through public and private donors.
Result-Oriented: Increase access to basic healthcare services by 50% in targeted underserved communities within one year.
Time-Bound: Secure funding and finalize mobile clinic routes within 3 months, procure equipment and medicines within 6 months, and begin service delivery within 1 year.
Impact Assessment:
3.b.3: Monitor the availability and affordability of essential medicines in mobile clinics, ensuring equitable access for patients in underserved communities.
Project 7: Community Health Worker Training and Empowerment
Specific: Train and empower community health workers to provide basic healthcare services, including screening for chronic diseases and promoting medication adherence.
Measurable: Track the number of community health workers trained, monitor the number of patients screened and referred for further care.
Achievable: Partner with national health ministries and NGOs with expertise in community health programs, develop localized training materials.
Result-Oriented: Increase the number of individuals screened for chronic diseases in target communities by 40% within one year.
Time-Bound: Develop training curriculum within 2 months, conduct training workshops within 3 months, and deploy community health workers within 6 months.
Impact Assessment:
3.b.3: Track the availability and affordability of essential medications for chronic diseases based on screenings and referrals conducted by trained community health workers.
Project 8: Price Transparency and Negotiation for Essential Medicines
Specific: Implement a national price transparency system for essential medicines and advocate for collective bargaining with pharmaceutical companies.
Measurable: Track the availability of price data for essential medicines, monitor the reduction in average medicine prices.
Achievable: Partner with national regulatory bodies and patient advocacy groups, utilize existing price transparency initiatives from other countries.
Result-Oriented: Reduce the average price of essential medicines by 15% within two years.
Time-Bound: Develop a national price transparency platform within 3 months, conduct training for stakeholders within 6 months, and negotiate price reductions within 18 months.
Impact Assessment:
3.b.3: Monitor the increased affordability of essential medicines in both public and private health facilities as a result of price negotiations.
Project 9: Combating Counterfeit and Substandard Medicines
Specific: Strengthen national regulatory frameworks and enforcement mechanisms to combat the sale and distribution of counterfeit and substandard medicines.
Measurable: Track the number of reported cases of counterfeit medicines, monitor the seizure rates of illegal pharmaceuticals.
Achievable: Partner with international organizations like WHO and Interpol, train enforcement personnel, and raise public awareness.
Result-Oriented: Reduce the number of reported cases of counterfeit medicines by 20% within two years.
Time-Bound: Review and update national regulations within 3 months, conduct training workshops for enforcement personnel within 6 months, and launch public awareness campaigns within 1 year.
Impact Assessment:
3.b.3: Monitor the increased availability of genuine and safe essential medicines in pharmacies and healthcare facilities due to stricter regulations and reduced counterfeit circulation.
Project 10: Digital Health Literacy Campaigns for Medication Adherence
Specific: Launch digital health literacy campaigns to educate the public about the importance of medication adherence and responsible use of medicines.
Measurable: Track campaign reach through social media and online platforms, monitor changes in knowledge and attitudes towards medication adherence.
Achievable: Partner with healthcare professionals and technology companies, develop culturally-appropriate educational materials.
Result-Oriented: Increase public awareness of medication adherence by 30% within one year.
Time-Bound: Develop campaign materials within 2 months, launch the campaign for 3 months, and conduct post-campaign surveys within 1 month.
Impact Assessment:
3.b.3: Track the potential increase in the accessibility and affordability of medication refill programs and adherence support services as a result of public awareness campaigns.
ความคิดเห็น